Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
Giancarlo Agnelli et al. N Engl J Med. 2020 Abstract Background:Ā Recent guidelines recommend consideration of the use of oral edoxaban or rivaroxaban for the treatment of venous thromboembolism in patients with cancer. However, the benefit of these oral agents is limited by the increased risk of bleeding associated with their use. Methods:Ā This was a multinational, …
Leggi tutto “Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer”